103461-20-7
103461-20-7
Chemical Structure
Ellipravin
Synonym(s): SUN 4599
- CAS No.: 103461-20-7
- Formula:C22H23BrN2O5
- Molecular Weight:475.33
IUPAC Name: 9-hydroxy-5,11-dimethyl-2-((2R,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-6H-pyrido[4,3-b]carbazol-2-ium bromide
InChIKey: OKNKQPUDKRCBIK-MAVIPZKQSA-N
SMILES: CC1=C2C(NC3=C2C=C(O)C=C3)=C(C)C4=CC=[N+]([C@H]5[C@@H]([C@H]([C@H](CO5)O)O)O)C=C41.[Br-]
Biological Activity: Ellipravin (SUN 4599) is a glycoside. Ellipravin has anticancer activity against Lewis lung cancer[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ellipravin | Ellipravin (SUN 4599) is a glycoside. Ellipravin has anticancer activity against Lewis lung cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Harada N, et al. Synthesis and antitumor activity of quaternary salts of 2-(2'-oxoalkoxy)-9-hydroxyellipticines. Chem Pharm Bull (Tokyo). 1997 Jan;45(1):134-7. [Content Brief]
- [2]. Honda T, et al. Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents. J Med Chem. 1988 Jul;31(7):1295-305. [Content Brief]
Keywords
